SEC Filing Details

Detailed Financial Reporting & Filings

Access Aprea Therapeutics’ quarterly and annual reports, earnings disclosures, and SEC filings. These financial documents reflect our commitment to transparency, regulatory compliance, and delivering clear insight into our operational and fiscal performance.

Document Details

Form
Filing Date
Apr 1, 2026
Document Date
Mar 31, 2026
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Aprea Therapeutics
Issuer
Aprea Therapeutics, Inc.
Filer
Peters Richard